SG StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Niks Prof

0.230

0.000

Volume:- -

Turnover:- -

Market Cap:29.90M

PE:15.42

High:0.230

Open:0.230

Low:0.230

Close:0.230

52wk High:0.230

52wk Low:0.115

Shares:130.00M

Float Shares:13.30M

Volume Ratio:- -

T/O Rate:- -

Dividend:0.01

Dividend Rate:4.35%

EPS(TTM):0.015

EPS(LYR):0.016

ROE:10.05%

ROA:6.71%

PB:1.53

PE(LYR):14.38

Loading ...

Overview Company News Filings

Is Honest (HNST) Using Hydrorich Cream To Quietly Reposition Its Skincare Brand Strategy?

Simply Wall St.

Cochlear Valuation Check As Nucleus Nexa System Reaches US Veterans Through VA Clinics

Simply Wall St.

Procter & Gamble Balances Hydrogel Skincare Growth With Steady Dividends

Simply Wall St.

Niks Professional to Delist From Singapore Bourse Thursday

Assessing Oddity Tech (ODD) Valuation After Analyst Praise And METHODIQ Skincare Launch

Simply Wall St.

Shanghai Hile Bio-Technology Subsidiary to Buy 51% Stake in Seven Dental Clinics

MT Newswires Live

Musée Platinum Tokyo Launches DUO Hydrogen Treatment Across All Salons in Singapore

L'Oreal Doubles Stake in Swiss Skincare Company Galderma

One Man's Mission to Get Back $4 Million of Stolen Skincare Products -- WSJ

California to Issue $19.2M in Revenue Bonds for Clinics, Offices

Monash Says Victorian Department of Health Determines Imposition of Conditions for Registrations of Victoria Clinics

MT Newswires Live

Sisram Medical Launches Universkin by Alma in Hong Kong, Pioneering a New Era of AI-assisted Personalized Skincare

Market Chatter: L'Oreal Buys Minority Stake in Chinese Skincare Brand

MT Newswires Live

Vexev's VxWave System Successfully Meets Clinical Endpoints in Landmark Study Evaluating Robotic Ultrasound Scanning for Mapping Vascular Access at U.S. Renal Care Dialysis Clinics

A NEW DAWN OF HOLISTIC WELLNESS AT THE RITZ-CARLTON SPA SINGAPORE: REDEFINING LUXURY WITH THE FUTURE OF SKINCARE

Press Release: NewLake Capital Partners Reports Third Quarter 2025 Financial Results

Yomiuri: Kao to Launch New Premium Skincare Product From Its Kanebo Brand to Boost Sales in Asia

"World Hair Transplant Repair Day" Taking Place on 11/11 Shines Light on Proliferation, Dangers of Black-Market Hair Transplant Clinics Worldwide

Press Release: Algernon Announces CAD $4 Million Non-Dilutive Financing to Open Four Brain-Specific PET Scan Clinics in the U.S. for Early Stage Alzheimer's Detection

Niks Professional Proposes Delisting via Selective Capital Reduction; Shares Surge Over 17%

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NPL.SI/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NPL.SI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NPL.SI\",,,,,undefined,":{"symbol":"NPL.SI","market":"SI","secType":"STK","nameCN":"Niks Prof","latestPrice":0.23,"timestamp":1770708000000,"preClose":0.23,"halted":4,"volume":0,"delay":15,"changeRate":0,"nameEN":"Niks Prof","floatShares":13298844,"shares":130000000,"eps":0.014915,"marketStatus":"Delisted","change":0,"latestTime":"02-10 15:20:00 SGT Delay","open":0.23,"high":0.23,"low":0.23,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.014915,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770714960000},"marketStatusCode":2,"adr":0,"exchange":"SGX","adjPreClose":0.23,"openAndCloseTimeList":[[1770683400000,1770696000000],[1770699600000,1770714960000]],"volumeRatio":0,"lotSize":100,"tradeCurrency":"SGD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NPL.SI\",,,,,undefined,":{"symbol":"NPL.SI","floatShares":13298844,"roa":"6.71%","roe":"10.05%","lyrEps":0.015992,"shares":130000000,"dividePrice":0.01,"high":0.23,"amplitude":0,"preClose":0.23,"low":0.23,"week52Low":0.115,"pbRate":"1.53","psRate":"2.61","week52High":0.23,"institutionHeld":0,"latestPrice":0.23,"eps":0.014915,"divideRate":0.043478,"volume":0,"delay":15,"ttmEps":0.014915,"open":0.23,"dividendPayoutRate":0.6253126563281641,"dividendFrequency":"A","dividendGrowthYears":0,"fiveYearAvgDividendRate":0.07072135785007072},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NPL.SI\",params:#limit:5,,,undefined,":[{"market":"SI","date":"2026-01-22","symbol":"NPL.SI","reason":null,"defaultRemindTime":1769041800000,"announcedDate":"2026-01-20","type":"delisting","dateTimestamp":1769011200000},{"date":"2025-05-02","symbol":"NPL.SI","amount":0.01,"announcedDate":"2025-04-24","type":"dividend","lastAmount":null,"market":"SI","newRecordDate":"2025-05-05","defaultRemindTime":1746145800000,"name":"新加坡阅肤有限公司","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-13","payableDate":"2025-05-05","currency":"SGD","dateTimestamp":1746115200000,"payDate":"2025-05-13"},{"date":"2024-05-16","symbol":"NPL.SI","amount":0.01,"announcedDate":"2024-05-03","type":"dividend","market":"SI","newRecordDate":"2024-05-17","defaultRemindTime":1715819400000,"name":"新加坡阅肤有限公司","recordDate":"2024-05-27","payableDate":"2024-05-17","currency":"SGD","dateTimestamp":1715788800000,"payDate":"2024-05-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NPL.SI\",market:\"SI\",,,undefined,":[{"executeDate":"2024-05-16","recordDate":"2024-05-17","paymentDate":"2024-05-27","value":0.01,"currency":"SGD"},{"executeDate":"2025-05-02","recordDate":"2025-05-05","paymentDate":"2025-05-13","value":0.01,"currency":"SGD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NPL.SI\",market:\"SI\",delay:true,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/sistock/value_analysis/stock/NPL.SI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:true,algorithm:1,,,undefined,":{"brief":{"id":"NPL.SI","date":"2026-01-22","current":15.420717,"percent":0.932203,"low":7.433949,"twenty":11.282051,"median":11.797153,"eighty":13.384615,"high":15.42032,"avg":12.416059,"sd":1.597902,"marketCap":29900000},"quantilePoints":[{"date":"2023-10-30","current":9.410062,"twenty":9.410062,"median":9.410062,"eighty":9.410062,"marketCap":26000000},{"date":"2023-11-27","current":9.363011,"twenty":9.372421,"median":9.386537,"eighty":9.400652,"marketCap":25870000},{"date":"2024-01-15","current":7.433949,"twenty":8.205574,"median":9.363011,"eighty":9.391242,"marketCap":20540000},{"date":"2024-01-22","current":7.433949,"twenty":7.433949,"median":8.39848,"eighty":9.381831,"marketCap":20540000},{"date":"2024-03-15","current":11.565836,"twenty":8.205574,"median":10.487949,"eighty":11.565836,"marketCap":19500000},{"date":"2024-03-22","current":11.565836,"twenty":9.381831,"median":11.565836,"eighty":11.565836,"marketCap":19500000},{"date":"2024-03-28","current":11.565836,"twenty":9.841217,"median":11.565836,"eighty":11.565836,"marketCap":19500000},{"date":"2024-04-05","current":11.565836,"twenty":11.565836,"median":11.565836,"eighty":11.565836,"marketCap":19500000},{"date":"2024-04-12","current":13.030842,"twenty":11.565836,"median":11.565836,"eighty":11.565836,"marketCap":21970000},{"date":"2024-04-19","current":13.030842,"twenty":11.565836,"median":11.565836,"eighty":13.030842,"marketCap":21970000},{"date":"2024-04-26","current":13.030842,"twenty":11.565836,"median":11.565836,"eighty":13.030842,"marketCap":21970000},{"date":"2024-05-03","current":13.030842,"twenty":11.565836,"median":11.565836,"eighty":13.030842,"marketCap":21970000},{"date":"2024-05-10","current":13.030842,"twenty":11.565836,"median":11.565836,"eighty":13.030842,"marketCap":21970000},{"date":"2024-05-17","current":12.491103,"twenty":11.565836,"median":12.028469,"eighty":13.030842,"marketCap":21060000},{"date":"2024-05-24","current":12.491103,"twenty":11.565836,"median":12.491103,"eighty":13.030842,"marketCap":21060000},{"date":"2024-05-31","current":11.797153,"twenty":11.565836,"median":12.491103,"eighty":13.030842,"marketCap":19890000},{"date":"2024-06-07","current":11.797153,"twenty":11.565836,"median":12.491103,"eighty":13.030842,"marketCap":19890000},{"date":"2024-06-14","current":11.720047,"twenty":11.565836,"median":11.797153,"eighty":13.030842,"marketCap":19760000},{"date":"2024-06-21","current":11.565836,"twenty":11.565836,"median":11.797153,"eighty":13.030842,"marketCap":19500000},{"date":"2024-06-28","current":11.642942,"twenty":11.565836,"median":11.797153,"eighty":13.030842,"marketCap":19630000},{"date":"2024-07-05","current":11.642942,"twenty":11.565836,"median":11.720047,"eighty":13.030842,"marketCap":19630000},{"date":"2024-07-12","current":11.642942,"twenty":11.565836,"median":11.720047,"eighty":13.030842,"marketCap":19630000},{"date":"2024-07-19","current":11.642942,"twenty":11.565836,"median":11.642942,"eighty":13.030842,"marketCap":19630000},{"date":"2024-07-26","current":11.642942,"twenty":11.565836,"median":11.642942,"eighty":13.030842,"marketCap":19630000},{"date":"2024-08-02","current":11.642942,"twenty":11.565836,"median":11.642942,"eighty":13.030842,"marketCap":19630000},{"date":"2024-08-08","current":11.103203,"twenty":11.565836,"median":11.642942,"eighty":12.969158,"marketCap":18720000},{"date":"2024-08-16","current":11.709402,"twenty":11.565836,"median":11.642942,"eighty":12.72242,"marketCap":17810000},{"date":"2024-08-23","current":12.051282,"twenty":11.565836,"median":11.642942,"eighty":12.676157,"marketCap":18330000},{"date":"2024-08-30","current":12.649573,"twenty":11.565836,"median":11.642942,"eighty":12.649573,"marketCap":19240000},{"date":"2024-09-06","current":11.196581,"twenty":11.565836,"median":11.642942,"eighty":12.649573,"marketCap":17030000},{"date":"2024-09-13","current":11.196581,"twenty":11.565836,"median":11.642942,"eighty":12.649573,"marketCap":17030000},{"date":"2024-09-20","current":11.196581,"twenty":11.565836,"median":11.642942,"eighty":12.617879,"marketCap":17030000},{"date":"2024-09-27","current":10.940171,"twenty":11.565836,"median":11.642942,"eighty":12.491103,"marketCap":16640000},{"date":"2024-10-04","current":11.282051,"twenty":11.282051,"median":11.642942,"eighty":12.491103,"marketCap":17160000},{"date":"2024-10-11","current":11.709402,"twenty":11.196581,"median":11.642942,"eighty":12.491103,"marketCap":17810000},{"date":"2024-10-18","current":11.794872,"twenty":11.213675,"median":11.642942,"eighty":12.491103,"marketCap":17940000},{"date":"2024-10-25","current":11.965812,"twenty":11.282051,"median":11.642942,"eighty":12.491103,"marketCap":18200000},{"date":"2024-11-01","current":11.794872,"twenty":11.282051,"median":11.642942,"eighty":12.491103,"marketCap":17940000},{"date":"2024-11-08","current":11.794872,"twenty":11.282051,"median":11.642942,"eighty":12.491103,"marketCap":17940000},{"date":"2024-11-15","current":11.794872,"twenty":11.282051,"median":11.642942,"eighty":12.491103,"marketCap":17940000},{"date":"2024-11-22","current":11.794872,"twenty":11.282051,"median":11.709402,"eighty":12.491103,"marketCap":17940000},{"date":"2024-11-29","current":11.111111,"twenty":11.282051,"median":11.642942,"eighty":12.393162,"marketCap":16900000},{"date":"2024-12-06","current":11.367521,"twenty":11.282051,"median":11.642942,"eighty":12.393162,"marketCap":17290000},{"date":"2024-12-13","current":11.367521,"twenty":11.282051,"median":11.642942,"eighty":12.307692,"marketCap":17290000},{"date":"2024-12-20","current":12.820513,"twenty":11.196581,"median":11.642942,"eighty":12.307692,"marketCap":19500000},{"date":"2024-12-27","current":12.820513,"twenty":11.196581,"median":11.642942,"eighty":12.491103,"marketCap":19500000},{"date":"2025-01-03","current":11.111111,"twenty":11.196581,"median":11.642942,"eighty":12.491103,"marketCap":16900000},{"date":"2025-01-10","current":11.282051,"twenty":11.196581,"median":11.642942,"eighty":12.491103,"marketCap":17160000},{"date":"2025-01-17","current":11.282051,"twenty":11.247863,"median":11.642942,"eighty":12.432338,"marketCap":17160000},{"date":"2025-01-24","current":11.282051,"twenty":11.282051,"median":11.642942,"eighty":12.393162,"marketCap":17160000},{"date":"2025-01-31","current":11.282051,"twenty":11.282051,"median":11.642942,"eighty":12.376068,"marketCap":17160000},{"date":"2025-02-07","current":11.282051,"twenty":11.282051,"median":11.642942,"eighty":12.307692,"marketCap":17160000},{"date":"2025-02-14","current":11.282051,"twenty":11.282051,"median":11.642942,"eighty":12.307692,"marketCap":17160000},{"date":"2025-02-21","current":11.367521,"twenty":11.282051,"median":11.642942,"eighty":12.307692,"marketCap":17290000},{"date":"2025-02-28","current":13.247863,"twenty":11.282051,"median":11.642942,"eighty":12.471515,"marketCap":20150000},{"date":"2025-03-07","current":12.820513,"twenty":11.282051,"median":11.642942,"eighty":12.491103,"marketCap":19500000},{"date":"2025-03-14","current":12.820513,"twenty":11.282051,"median":11.642942,"eighty":12.491103,"marketCap":19500000},{"date":"2025-03-21","current":12.820513,"twenty":11.282051,"median":11.642942,"eighty":12.649573,"marketCap":19500000},{"date":"2025-03-28","current":12.820513,"twenty":11.282051,"median":11.642942,"eighty":12.800894,"marketCap":19500000},{"date":"2025-04-04","current":12.820513,"twenty":11.282051,"median":11.642942,"eighty":12.820513,"marketCap":19500000},{"date":"2025-04-11","current":9.379509,"twenty":11.282051,"median":11.642942,"eighty":12.820513,"marketCap":19500000},{"date":"2025-04-17","current":9.379509,"twenty":11.282051,"median":11.642942,"eighty":12.820513,"marketCap":19500000},{"date":"2025-04-25","current":10.1924,"twenty":11.264957,"median":11.642942,"eighty":12.820513,"marketCap":21190000},{"date":"2025-05-02","current":10.942761,"twenty":11.196581,"median":11.642942,"eighty":12.820513,"marketCap":22750000},{"date":"2025-05-09","current":9.50457,"twenty":11.196581,"median":11.642942,"eighty":12.761657,"marketCap":19760000},{"date":"2025-05-16","current":10.44252,"twenty":11.196581,"median":11.642942,"eighty":12.72242,"marketCap":21710000},{"date":"2025-05-23","current":10.942761,"twenty":11.196581,"median":11.642942,"eighty":12.693281,"marketCap":22750000},{"date":"2025-05-30","current":12.068302,"twenty":11.196581,"median":11.642942,"eighty":12.649573,"marketCap":25090000},{"date":"2025-06-06","current":12.005772,"twenty":11.196581,"median":11.642942,"eighty":12.649573,"marketCap":24960000},{"date":"2025-06-13","current":11.880712,"twenty":11.196581,"median":11.642942,"eighty":12.649573,"marketCap":24700000},{"date":"2025-06-20","current":11.755652,"twenty":11.196581,"median":11.642942,"eighty":12.615385,"marketCap":24440000},{"date":"2025-06-27","current":11.693122,"twenty":11.196581,"median":11.642942,"eighty":12.540867,"marketCap":24310000},{"date":"2025-07-04","current":11.380471,"twenty":11.196581,"median":11.642942,"eighty":12.500049,"marketCap":23660000},{"date":"2025-07-11","current":11.693122,"twenty":11.196581,"median":11.642942,"eighty":12.491103,"marketCap":24310000},{"date":"2025-07-18","current":12.005772,"twenty":11.196581,"median":11.642942,"eighty":12.491103,"marketCap":24960000},{"date":"2025-07-25","current":12.005772,"twenty":11.196581,"median":11.642942,"eighty":12.491103,"marketCap":24960000},{"date":"2025-08-01","current":12.130832,"twenty":11.196581,"median":11.642942,"eighty":12.491103,"marketCap":25220000},{"date":"2025-08-08","current":12.130832,"twenty":11.196581,"median":11.642942,"eighty":12.491103,"marketCap":25220000},{"date":"2025-08-15","current":13.006704,"twenty":11.196581,"median":11.642942,"eighty":12.491103,"marketCap":25220000},{"date":"2025-08-22","current":13.006704,"twenty":11.196581,"median":11.642942,"eighty":12.491103,"marketCap":25220000},{"date":"2025-08-29","current":12.872615,"twenty":11.196581,"median":11.693122,"eighty":12.649573,"marketCap":24960000},{"date":"2025-09-05","current":12.872615,"twenty":11.196581,"median":11.693122,"eighty":12.72242,"marketCap":24960000},{"date":"2025-09-12","current":15.085095,"twenty":11.196581,"median":11.693122,"eighty":12.820513,"marketCap":29250000},{"date":"2025-09-19","current":15.085095,"twenty":11.220113,"median":11.701262,"eighty":12.820513,"marketCap":29250000},{"date":"2025-09-26","current":15.085095,"twenty":11.255411,"median":11.709402,"eighty":12.820513,"marketCap":29250000},{"date":"2025-10-03","current":15.085095,"twenty":11.255411,"median":11.709402,"eighty":12.820513,"marketCap":29250000},{"date":"2025-10-10","current":15.085095,"twenty":11.255411,"median":11.720047,"eighty":12.820513,"marketCap":29250000},{"date":"2025-10-17","current":15.085095,"twenty":11.266067,"median":11.720047,"eighty":12.820513,"marketCap":29250000},{"date":"2025-10-24","current":15.085095,"twenty":11.282051,"median":11.755652,"eighty":12.820513,"marketCap":29250000},{"date":"2025-10-31","current":15.085095,"twenty":11.282051,"median":11.755652,"eighty":12.872615,"marketCap":29250000},{"date":"2025-11-07","current":15.085095,"twenty":11.282051,"median":11.794872,"eighty":12.872615,"marketCap":29250000},{"date":"2025-11-14","current":15.085095,"twenty":11.282051,"median":11.794872,"eighty":12.872615,"marketCap":29250000},{"date":"2025-11-21","current":15.42032,"twenty":11.282051,"median":11.794872,"eighty":13.006704,"marketCap":29900000},{"date":"2025-11-28","current":15.42032,"twenty":11.282051,"median":11.794872,"eighty":13.006704,"marketCap":29900000},{"date":"2025-12-05","current":15.085095,"twenty":11.282051,"median":11.794872,"eighty":13.030842,"marketCap":29250000},{"date":"2025-12-12","current":15.085095,"twenty":11.282051,"median":11.794872,"eighty":13.030842,"marketCap":29250000},{"date":"2025-12-19","current":15.085095,"twenty":11.282051,"median":11.794872,"eighty":13.030842,"marketCap":29250000},{"date":"2025-12-26","current":15.42032,"twenty":11.282051,"median":11.794872,"eighty":13.030842,"marketCap":29900000},{"date":"2026-01-02","current":15.42032,"twenty":11.282051,"median":11.794872,"eighty":13.030842,"marketCap":29900000},{"date":"2026-01-09","current":15.42032,"twenty":11.282051,"median":11.794872,"eighty":13.030842,"marketCap":29900000},{"date":"2026-01-16","current":15.42032,"twenty":11.282051,"median":11.797153,"eighty":13.247863,"marketCap":29900000},{"date":"2026-01-22","current":15.42032,"twenty":11.282051,"median":11.797153,"eighty":13.384615,"marketCap":29900000}],"updateTime":1770676093068},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NPL.SI\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610653053","title":"Is Honest (HNST) Using Hydrorich Cream To Quietly Reposition Its Skincare Brand Strategy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2610653053","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610653053?lang=en_us&edition=fundamental","pubTime":"2026-02-09 19:27","pubTimestamp":1770636426,"startTime":"0","endTime":"0","summary":"The Honest Company, Inc. recently launched its new Hydrorich Cream, a clinically tested moisturizer formulated with dual Hyaluronic Acid to deliver up to 48 hours of hydration for dry to extra-dry skin.\nThis richer addition to Honest’s skincare lineup underscores the brand’s focus on barrier-supporting, high-performance formulas tailored to seasonal and intensive moisture needs.\nWe’ll now explore how this advanced Hydrorich Cream launch, emphasizing long-lasting hydration benefits, shapes...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/household/nasdaq-hnst/honest/news/is-honest-hnst-using-hydrorich-cream-to-quietly-reposition-i","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/household/nasdaq-hnst/honest/news/is-honest-hnst-using-hydrorich-cream-to-quietly-reposition-i","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK6100","HNST","NPL.SI","BK4183","BK4539"],"gpt_icon":0},{"id":"2605140804","title":"Cochlear Valuation Check As Nucleus Nexa System Reaches US Veterans Through VA Clinics","url":"https://stock-news.laohu8.com/highlight/detail?id=2605140804","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605140804?lang=en_us&edition=fundamental","pubTime":"2026-01-22 21:17","pubTimestamp":1769087861,"startTime":"0","endTime":"0","summary":"What Cochlear’s VA access milestone could mean for shareholders\nCochlear (ASX:COH) has flagged a new chapter for its flagship Nucleus Nexa System. The device is now available to eligible US military veterans through VA clinics nationwide, opening an additional access point in a key healthcare channel.\nSee our latest analysis for Cochlear.\nWhile Cochlear’s A$270.22 share price has seen a 3.44% 1 month share price return, the 90 day share price return of 7.24% and 1 year total shareholder...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlear-valuation-check-as-nucleus-nexa-system-reaches-us-v","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlear-valuation-check-as-nucleus-nexa-system-reaches-us-v","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NPL.SI","DCF","BK7007","BK6100","COH.AU"],"gpt_icon":0},{"id":"2605617219","title":"Procter & Gamble Balances Hydrogel Skincare Growth With Steady Dividends","url":"https://stock-news.laohu8.com/highlight/detail?id=2605617219","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605617219?lang=en_us&edition=fundamental","pubTime":"2026-01-21 14:30","pubTimestamp":1768977052,"startTime":"0","endTime":"0","summary":"Procter & Gamble (NYSE:PG) is expanding further into advanced skincare with a growing presence in the hydrogel face mask market.\nThe company continues its 135-year record of uninterrupted dividends, including a recent 5% dividend increase.\nP&G highlights both product expansion in premium beauty and ongoing income returns to shareholders.\n\nFor you as an investor, P&G sits at the intersection of everyday consumer staples and higher end skincare, and the hydrogel face mask push shows how the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/33328-main-header/1756194107264","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/33328-main-header/1756194107264"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/household/nyse-pg/procter-gamble/news/procter-gamble-balances-hydrogel-skincare-growth-with-steady","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/household/nyse-pg/procter-gamble/news/procter-gamble-balances-hydrogel-skincare-growth-with-steady","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1868836757.USD","LU0942090050.USD","LU0323591593.USD","IE00B1XK9C88.USD","LU2129689514.USD","IE000M9KFDE8.USD","IE00BN8TJ469.HKD","LU0868494708.USD","LU1430594728.SGD","LU0868494617.USD","LU1280957306.USD","LU2129689605.HKD","LU1868836591.USD","SG9999002224.SGD","LU1585245621.USD","LU1868837136.USD","LU2552382058.USD","SG9999001440.SGD","GB00BDT5M118.USD","LU2129689431.USD","BK4581","LU2242652126.USD","BK4567","IE00BLSP4239.USD","SG9999015341.SGD","BK4559","BK4534","LU1066051498.USD","SG9999014542.SGD","LU1066053197.SGD","LU2552382215.SGD","LU1162221912.USD","BK4585","LU0640476718.USD","LU1929549753.HKD","LU0098860793.USD","LU0061475181.USD","BK4018","SG9999014559.SGD","BK4550","BK4558","LU0689626769.HKD","IE00B3T34201.USD","PG","LU2242646821.SGD","LU0234572021.USD","BK4504","NPL.SI","BK4588","LU0320765646.SGD"],"gpt_icon":0},{"id":"2604150076","title":"Niks Professional to Delist From Singapore Bourse Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2604150076","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604150076?lang=en_us&edition=fundamental","pubTime":"2026-01-20 10:46","pubTimestamp":1768877204,"startTime":"0","endTime":"0","summary":"The SGX-ST granted Niks Professional  approval to delist its shares on Thursday, Jan. 22, according to a Tuesday filing with the Singapore Exchange.The company first disclosed its plans to delist from the Singapore bourse in September 2025 via a selective capital reduction process.The move was prompted by the medical skin care provider's low trading liquidity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NPL.SI","BK6100"],"gpt_icon":0},{"id":"2604450789","title":"Assessing Oddity Tech (ODD) Valuation After Analyst Praise And METHODIQ Skincare Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2604450789","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604450789?lang=en_us&edition=fundamental","pubTime":"2026-01-17 12:29","pubTimestamp":1768624166,"startTime":"0","endTime":"0","summary":"Oddity Tech (NasdaqGM:ODD) is back in focus after an influential analyst highlighted its recent skincare launch, METHODIQ, along with consistent revenue growth and EBITDA margins near 20%, which has helped lift investor interest in the stock.\nSee our latest analysis for Oddity Tech.\nAt a share price of $35.34, Oddity Tech has seen a 4.56% 1 day share price return, but weaker 30 day and 90 day share price returns of 16.34% and 30.50%, with a 1 year total shareholder return of 19.39%. This...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/5221000-choice1-main-header/1585186890345","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/5221000-choice1-main-header/1585186890345"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/household/nasdaq-odd/oddity-tech/news/assessing-oddity-tech-odd-valuation-after-analyst-praise-and","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/household/nasdaq-odd/oddity-tech/news/assessing-oddity-tech-odd-valuation-after-analyst-praise-and","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4023","BK4587","AI","NPL.SI","BK4528","ETH","BK6100","ODD","BK4551","BK4601","BK4543","BK4183","BK4588","BK4585","IE0009354923.USD"],"gpt_icon":0},{"id":"2600054160","title":"Shanghai Hile Bio-Technology Subsidiary to Buy 51% Stake in Seven Dental Clinics","url":"https://stock-news.laohu8.com/highlight/detail?id=2600054160","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600054160?lang=en_us&edition=fundamental","pubTime":"2026-01-02 16:37","pubTimestamp":1767343060,"startTime":"0","endTime":"0","summary":"Shanghai Hile Bio-Technology  subsidiary Shaanxi Ruisheng Biotechnology will acquire a 51% stake in seven dental clinics in Yangzhou and Changzhou, China, for 61.2 million yuan.The transaction is expected to contribute 7 million yuan in net profit in 2026, according to a Thusrday filing with the Shanghai bourse.The clinics will pledge the remaining 49% to Ruisheng Biotechnology to guarantee their performance and impairment compensation obligations, the filing said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NPL.SI","BK0070","BK0046","603718","BK6100","BK0239"],"gpt_icon":0},{"id":"2592924024","title":"Musée Platinum Tokyo Launches DUO Hydrogen Treatment Across All Salons in Singapore","url":"https://stock-news.laohu8.com/highlight/detail?id=2592924024","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592924024?lang=en_us&edition=fundamental","pubTime":"2025-12-18 14:00","pubTimestamp":1766037600,"startTime":"0","endTime":"0","summary":"SINGAPORE, Dec. 18, 2025 /PRNewswire/ -- Musée Platinum Tokyo, a leading beauty brand with over 15 years in Singapore, has officially launched the DUO HydrogenTreatment at all its salon locations. The non-invasive treatment is formulated for individualswith sensitive, acne-prone, eczema-prone, or reactive skin and is suitable for application to the face, scalp, and body, including delicate areas.The hydrogen treatment offers a gentle, restorative approach to skincare, helping to calm irritation, support hydration, and enhance skin resilience. It is recommended for individuals experiencing redness, dryness, or sensitivity triggered by environmental stressors or Singapore's humid climate.The launch responds to growing demand among individuals in Singapore for effective yet gentle treatments that support deeper skin recovery and long-term skin resilience. The technology is designed to complement existing aesthetic services, including body hair removal, with a particular focus on improving","market":"nz","thumbnail":"https://mma.prnewswire.com/media/2847564/Mus_e_Platinum_Tokyo_Launches_DUO_Hydrogen_Treatment_Across_All_Salons.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2847564/Mus_e_Platinum_Tokyo_Launches_DUO_Hydrogen_Treatment_Across_All_Salons.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/musee-platinum-tokyo-launches-duo-hydrogen-treatment-across-all-salons-in-singapore-302645321.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLmain","NPL.SI","BK6100"],"gpt_icon":0},{"id":"2589333527","title":"L'Oreal Doubles Stake in Swiss Skincare Company Galderma","url":"https://stock-news.laohu8.com/highlight/detail?id=2589333527","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589333527?lang=en_us&edition=fundamental","pubTime":"2025-12-08 17:17","pubTimestamp":1765185420,"startTime":"0","endTime":"0","summary":"L'Oreal is buying a stake in Galderma from an investor group, doubling its holding in the Swiss company to 20% in a deal that expands its footprint in dermatology.Financial terms weren't disclosed. The package of about 24 million Galderma shares would be valued at 3.9 billion francs  based on Friday's closing price of 162.80 francs. The seller is an investment group led by Sweden's EQT and includes Sunshine SwissCo, Abu Dhabi Investment Authority and Auba Investment, L'Oreal said.The deal deepens L'Oreal's footprint in skincare, having agreed to buy South Korean skincare brand Dr.G last December, and signing a deal to acquire a majority stake in Medik8, a U.K. skincare brand, earlier this year.The French cosmetics group, whose brands include Maybelline, Aesop and Lancome, founded Galderma with Nestle more than 40 years ago. After exiting the company in 2014, it returned to buy a 10% stake in 2024. Galderma focuses on injectable aesthetics and dermatological skincare treatments. The com","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6100","NPL.SI","BK4183","LRLCY"],"gpt_icon":0},{"id":"2589846517","title":"One Man's Mission to Get Back $4 Million of Stolen Skincare Products -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2589846517","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589846517?lang=en_us&edition=fundamental","pubTime":"2025-12-06 09:00","pubTimestamp":1764982800,"startTime":"0","endTime":"0","summary":"Max Medroso's nightmare started this summer when his natural skin-care business was waiting for a big shipment ordered for Amazon's Prime Day. At first, he thought, \"Shipments get delayed one week, two weeks all the time.\". This time was different. His $4 million shipment never arrived.Just days after Medroso's shipment went missing, he says goods branded with his company's name -- Sky & Sol -- popped up for sale on Amazon.com at deeply discounted prices. That is what led him to believe his cargo had been stolen.Suddenly the 25-year-old entrepreneur found himself in a maddening monthslong hunt to find the perpetrators. Medroso alternatively played the roles of detective, crusader and plaintiff. In a federal lawsuit, he laid out a group of companies that moved his goods from one seller to another with lightning speed before the goods appeared online.\"Amazon has zero tolerance for the sale of stolen goods, and we work hard to combat this industrywide issue,\" a spokesperson for the compan","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2087625088.SGD","LU1861127337.USD","BK4534","LU1720051017.SGD","IE00B3S45H60.SGD","LU0289960550.SGD","BK4598","IE00B19Z3B42.SGD","LU0158827948.USD","LU0061474960.USD","IE00BKPKM429.USD","LU1720051108.HKD","SGXZ81514606.USD","IE00BMPRXR70.SGD","LU0107464264.USD","LU0162691827.USD","LU2237957811.SGD","LU1718418525.SGD","LU2361044949.HKD","LU2361045086.USD","LU0310800379.SGD","LU0109392836.USD","LU0310799852.SGD","LU2083900584.USD","LU1127390331.HKD","LU0456855351.SGD","LU1814569148.SGD","LU1989764664.SGD","LU2720916845.USD","NPL.SI","AMZN","LU2247934214.USD","LU0070217475.USD","SG9999014906.USD","IE0001KFT4U8.USD","LU2746668461.USD","LU1153585028.USD","LU1037948541.HKD","LU0265550359.USD","LU2092627202.USD","LU0127658192.USD","LU1244550221.USD","BK4533","LU1261432733.SGD","LU1116320737.USD","LU1201861165.SGD","LU2403377893.USD","USAW.SI","IE00B775SV38.USD","LU0642271901.SGD"],"gpt_icon":1},{"id":"2589811056","title":"California to Issue $19.2M in Revenue Bonds for Clinics, Offices","url":"https://stock-news.laohu8.com/highlight/detail?id=2589811056","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589811056?lang=en_us&edition=fundamental","pubTime":"2025-12-06 01:59","pubTimestamp":1764957540,"startTime":"0","endTime":"0","summary":"The California Municipal Finance Authority is offering $19.2 million in revenue bonds to finance the purchase of two buildings to be used as a clinic and administrative offices for Gracelight Community Health.The bonds would be sold in two tranches, according to documents on MuniOS.The authority is selling $19.1 million in Series 2025 A bonds, and $175,000 in Series 2025 B federally taxable bonds.The Series 2025 A bonds mature from June 1, 2026, through 2035. The Series 2025 B bonds mature in 2026. Interest on the bonds will be payable beginning June 1, 2026, and on each subsequent June 1 and Dec. 1.Proceeds would be used to buy, construct, furnish and equip leasehold improvements within two different buildings in Los Angeles to use as clinics, and a building in Los Angeles for use as administrative offices.The California Municipal Finance Authority sells bonds and other obligations in order to support economic development, job creation and social programs throughout California.Piper S","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NPL.SI"],"gpt_icon":0},{"id":"2586027847","title":"Monash Says Victorian Department of Health Determines Imposition of Conditions for Registrations of Victoria Clinics","url":"https://stock-news.laohu8.com/highlight/detail?id=2586027847","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586027847?lang=en_us&edition=fundamental","pubTime":"2025-11-28 06:44","pubTimestamp":1764283492,"startTime":"0","endTime":"0","summary":"Monash IVF Group  said the Victorian Department of Health has determined to impose certain conditions on the registrations of its clinics in Victoria, after the embryo transfer mix-up at its Clayton lab, with the action effective Friday, according to a same-day filing with the Australian bourse.The conditions includes steps to verify the intended biological sources for each cycle, requirements for patient-management system, witnessing, checking and record-keeping, the filing said.The company said it does not expect the conditions to materially affect its operations or alter its earnings guidance, the filing added.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4095","VCCTF","BK7113","MVF.AU","NPL.SI","BK6100","BK7508"],"gpt_icon":0},{"id":"2585118461","title":"Sisram Medical Launches Universkin by Alma in Hong Kong, Pioneering a New Era of AI-assisted Personalized Skincare","url":"https://stock-news.laohu8.com/highlight/detail?id=2585118461","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585118461?lang=en_us&edition=fundamental","pubTime":"2025-11-21 16:15","pubTimestamp":1763712900,"startTime":"0","endTime":"0","summary":"HONG KONG, Nov. 21, 2025 /PRNewswire/ -- Sisram Medical Ltd , a global consumer wellness group offering Energy-Based Devices , injectables, and other complementary solutions, announced that Alma Lasers Ltd., a wholly-owned subsidiary of Sisram, has launched Universkin by Alma, the world's first AI-assisted skincare solution, in the Hong Kong market.Designed to meet the evolving needs of today's patients, Universkin by Alma redefines post-treatment care with a personalized, science-based approach. By integrating AI technology, physician expertise, and precision formulations, it transforms skincare into a continuous, journey-led experience that connects clinical treatments with daily routines for lasting, visible results.Sisram Medical Ltd  is a global leader in medical aesthetic solutions with over 25 years of expertise in Energy-Based Devices . Built on a legacy of innovation and clinical excellence, the Company's synergistic ecosystem spans EBD techn","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/sisram-medical-launches-universkin-by-alma-in-hong-kong-pioneering-a-new-era-of-ai-assisted-personalized-skincare-302622969.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6100","BK6502","BK4023","BK4585","BK4588","BK4587","AI","BK4543","BK4551","5OX.SI","BK6097","NPL.SI","BK4528"],"gpt_icon":0},{"id":"2584819984","title":"Market Chatter: L'Oreal Buys Minority Stake in Chinese Skincare Brand","url":"https://stock-news.laohu8.com/highlight/detail?id=2584819984","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584819984?lang=en_us&edition=fundamental","pubTime":"2025-11-18 15:52","pubTimestamp":1763452355,"startTime":"0","endTime":"0","summary":"L'Oreal purchased a minority stake in Chinese skincare brand Lan for an undisclosed sum, Reuters reported Monday, citing a company statement.The stake purchase highlights China's role in L'Oreal's global strategy, the news agency reported, citing North Asia President and China CEO Vincent Boinay.\"We firmly believe investing in China is investing in the future, and we will continue to cultivate the Chinese market, work with more Chinese brands to create a beautiful future and meet the expectations of sophisticated Chinese consumers,\" Reuters quoted Boinay as saying.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK6502","NPL.SI","5OX.SI","BK6097","BK6100"],"gpt_icon":0},{"id":"2582385652","title":"Vexev's VxWave System Successfully Meets Clinical Endpoints in Landmark Study Evaluating Robotic Ultrasound Scanning for Mapping Vascular Access at U.S. Renal Care Dialysis Clinics","url":"https://stock-news.laohu8.com/highlight/detail?id=2582385652","media":"prnewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582385652?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:32","pubTimestamp":1762810320,"startTime":"0","endTime":"0","summary":"VxWave Ultrasound Imaging System demonstrated 94% scanning success rate and 100% data adequacy rate for vascular access creation strategies in CANSCAN trial. New insights into vascular anatomy made possible by standardized image acquisition and reporting. VxWave System has the potential to significantly advance standardization of vascular assessment at the point of care. SYDNEY and SAN ANTONIO, Nov. 11, 2025 /PRNewswire/ -- Vexev, an Australian-based medical device company advancing next-generation vascular imaging, and U.S. Renal Care, a leading provider of in-center and home dialysis in the United States, announced the highly successful results of the CANSCAN Trial , providing evidence that the VxWave Ultrasound Imaging System can reliably perform semi-autonomous vascular mapping examinations directly within the dialysis clinic. Dr. Varshi Broumand, CANSCAN Study Principal Investigator, presented the results during the American Society of Nephrology's annual meeting, Kidney Week 2025","market":"sh","thumbnail":"https://mma.prnewswire.com/media/2738052/Vexev_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2738052/Vexev_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/vexevs-vxwave-system-successfully-meets-clinical-endpoints-in-landmark-study-evaluating-robotic-ultrasound-scanning-for-mapping-vascular-access-at-us-renal-care-dialysis-clinics-302609522.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVG","LU0106261612.USD","LU0012050646.USD","AVG.AU","BK4189","BK7097","BK7505","LARK","LU2211817866.USD","LU2308191902.HKD","LU0256331488.USD","LU1721429741.USD","NPL.SI","LU1721429402.USD","LU2380233275.USD","DAR","BK6100","BK4211"],"gpt_icon":0},{"id":"2581058100","title":"A NEW DAWN OF HOLISTIC WELLNESS AT THE RITZ-CARLTON SPA SINGAPORE: REDEFINING LUXURY WITH THE FUTURE OF SKINCARE","url":"https://stock-news.laohu8.com/highlight/detail?id=2581058100","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581058100?lang=en_us&edition=fundamental","pubTime":"2025-11-06 14:00","pubTimestamp":1762408800,"startTime":"0","endTime":"0","summary":"The Ritz-Carlton Spa introduces Southeast Asia's first exclusive partnership with EPICUTIS  , pharmaceutical-grade, science-backedskincare. SINGAPORE, Nov. 6, 2025 /PRNewswire/ -- The Ritz-Carlton, Millenia Singapore is pleased to announce the Southeast Asia debut of innovative, science-driven skincare brand EPICUTIS, developed by biotech innovator Signum Biosciences. In this exclusive partnership, The Ritz-Carlton Spa Singapore has been designated as the brand's flagship property in the region, where holistic harmony intertwines with the forefront of skincare innovation.The EPICUTISScience-first Philosophy Adopting a science-first philosophy, EPICUTISredefines clean beauty standards. Developed in one of the world's most advanced scientific laboratories by renowned Princeton biophysicist Dr. Jeffry Stock, EPICUTIS is the first professional skincare line to apply pharmaceutical research technologies to topical formulations. In collaboration with master formulator Masanori Tamura, EPICUT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/a-new-dawn-of-holistic-wellness-at-the-ritz-carlton-spa-singapore-redefining-luxury-with-the-future-of-skincare-302605340.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["Z4D.SI","MAR","BK4539","BK6100","BK4588","BK6502","BK4142","LU1718418525.SGD","DAWN","BK4585","BK6046","BK6097","5OX.SI","BK6088","NPL.SI","IE00B0T0GQ85.USD","IE00B1G9WX41.USD","IE00B45NX917.SGD","IE00B95QR487.USD","BK4139","IE00BD0PCF45.HKD"],"gpt_icon":0},{"id":"2581958089","title":"Press Release: NewLake Capital Partners Reports Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2581958089","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581958089?lang=en_us&edition=fundamental","pubTime":"2025-11-06 07:44","pubTimestamp":1762386240,"startTime":"0","endTime":"0","summary":"Third Quarter 2025 Revenue Totaled $12.6 Million, an Increase of 0.3% Year-Over-Year. Third Quarter 2025 Net Income Attributable to Common Stockholders Totaled $6.7 Million, Funds from Operations Totaled $10.7 Million, and Adjusted Funds from Operations Totaled $11.0 Million. Conference Call and Webcast Scheduled for November 6, 2025, at 11 a.m. Eastern Time. NEW CANAAN, Conn., Nov. 05, 2025  -- NewLake Capital Partners, Inc.  , a leading provider of real estate capital to state-licensed cannabis operators, today announced its financial results for the third quarter ended September 30, 2025.\"During the third quarter we remained focused on proactive tenant management while maintaining the strength of our balance sheet,\" said Anthony Coniglio, NewLake's President and Chief Executive Officer. \"Despite continued cannabis industry headwinds, NewLake is positioned to deliver lasting value for our shareholders.\". -- Net income attributable to common stockholders totaled $6.7 million.-- Adjust","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4171","NLCP","BK6100","BK4224","NPL.SI","CFA.SI"],"gpt_icon":0},{"id":"2580003522","title":"Yomiuri: Kao to Launch New Premium Skincare Product From Its Kanebo Brand to Boost Sales in Asia","url":"https://stock-news.laohu8.com/highlight/detail?id=2580003522","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580003522?lang=en_us&edition=fundamental","pubTime":"2025-11-04 16:07","pubTimestamp":1762243620,"startTime":"0","endTime":"0","summary":"Kao Corp. has announced that it will launch a new toner from its flagship cosmetics brand Kanebo in January or later. The company aims to strengthen its premium skincare line in the growing Asian market.The toner, called Kanebo Generating Essentials, incorporates a unique moisturizing ingredient inspired by vernix caseosa -- the protective substance covering a baby's skin in the womb -- that has been refined into a micro-sized formulation. The toner is designed to quickly absorb into the skin, giving it a plump but firm feel.The same ingredient is also included in Kanebo's face cream, which was launched in September. Kao positions the new toner, priced at 13,200 yen including tax, as its flagship product to be used with the face cream, the company said Friday.Kanebo is one of six brands Kao is focusing on for international expansion, with a goal to grow its sales by 60% by 2027 compared to 2024.This article is from The Yomiuri Shimbun. Neither Dow Jones Newswires, MarketWatch, Barron's","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NPL.SI","5OX.SI"],"gpt_icon":0},{"id":"2579903062","title":"\"World Hair Transplant Repair Day\" Taking Place on 11/11 Shines Light on Proliferation, Dangers of Black-Market Hair Transplant Clinics Worldwide","url":"https://stock-news.laohu8.com/highlight/detail?id=2579903062","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579903062?lang=en_us&edition=fundamental","pubTime":"2025-10-29 20:11","pubTimestamp":1761739860,"startTime":"0","endTime":"0","summary":"ISHRS Hosts Live Surgery Workshop in Bucharest, Romania, November 7-9, 2025,  focusing on hair repair  CHICAGO, Oct. 29, 2025 /PRNewswire/ --According to a recent member survey conducted by the International Society of Hair Restoration Surgery , the impact of black-market hair transplant clinics continues to reverberate around the world –with more clinics opening and more complications for the countless victims of these unscrupulous practices.Case in point: earlier this month, Dubai police arrested a man running an illegal hair transplant clinic from an apartment.The International Society of Hair Restoration Surgery hosts its fifth annual \"World Hair Transplant Repair Day\" on 11.11 to raise awareness of the dangers of black-market hair transplant clinics around the world.The ISHRS receives numerous emails from young men who have fallen victim. In late-September 2025, the ISHRS received the following message from a man in the United Kingdom, \"Hi, I got a botched hair transplant and my d","market":"sh","thumbnail":"https://mma.prnewswire.com/media/1811888/ISHRS_LOGO_blue_no_oval_CMYK_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/1811888/ISHRS_LOGO_blue_no_oval_CMYK_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/world-hair-transplant-repair-day-taking-place-on-1111-shines-light-on-proliferation-dangers-of-black-market-hair-transplant-clinics-worldwide-302592189.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6100","NPL.SI"],"gpt_icon":0},{"id":"2570995490","title":"Press Release: Algernon Announces CAD $4 Million Non-Dilutive Financing to Open Four Brain-Specific PET Scan Clinics in the U.S. for Early Stage Alzheimer's Detection","url":"https://stock-news.laohu8.com/highlight/detail?id=2570995490","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570995490?lang=en_us&edition=fundamental","pubTime":"2025-09-25 19:00","pubTimestamp":1758798000,"startTime":"0","endTime":"0","summary":"VANCOUVER, British Columbia, Sept. 25, 2025  -- Algernon Pharmaceuticals Inc.    , a Canadian healthcare company announces that it has signed a definitive equipment order and financing agreement with Catalyst MedTech for the provision of four, U.S. FDA cleared Oncovision CareMiBrain brain-specific, Positron Emission Tomography  scanner systems to be utilized in four planned Algernon neuroimaging medical clinics. This represents a non-dilutive deal valued at over CAD $4 million and includes an agreement to acquire an additional six systems for the establishment of additional U.S. clinics, on an adjusted cost basis.The terms include financing the scanners with a 20% deposit by the Company, with monthly payments at an average annual interest rate of 7% per annum, and a balloon payment owing after 2 years of operations. Since the PET scanner represents approximately 80% of the capital costs required by Algernon to open a neuroimaging clinic, this is a key transaction for the Company under ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","AGNPF","BK6505","BK4099","NPL.SI","N0Z.SI","BK4555","BK6100","BK4604","TM","BK4585","03160","SSI","BK6096"],"gpt_icon":0},{"id":"2566559079","title":"Niks Professional Proposes Delisting via Selective Capital Reduction; Shares Surge Over 17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566559079","media":"MT Newswires","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566559079?lang=en_us&edition=fundamental","pubTime":"2025-09-11 13:25","pubTimestamp":1757568311,"startTime":"0","endTime":"0","summary":"Niks Professional  will undertake a delisting exercise through a selective capital reduction process, according to a filing with the Singapore Exchange on Thursday.The company's current issued and paid-up share capital is SG$6.5 million, comprising 130 million shares.The selective capital reduction will serve as an exit offer to eligible shareholders, with the company looking to reduce the share capital by SG$5.1 million and canceling around 22.4 million shares, with the aggregate sum returned to shareholders at SG$0.23 per share.The company has decided to take this course due to low trading liquidity, the filing said.Shares of the company surged over 17% in Thursday trading.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Niks Professional Proposes Delisting via Selective Capital Reduction; Shares Surge Over 17%","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NPL.SI","BK6100"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}]}}